Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants

Vaccine

Volumn 22, Issue 17-18, 2004, Pages 2226-2233

  Zepp, F ^a   Knuf, M ^a   Heininger, U ^b   Jahn, K ^a   Collard, A ^c   Habermehl, P ^a   Schuerman, L ^c   Sanger R ^c  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

^c GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Combination pediatric vaccines; DTPa; DTPa HBV IPV Hib

Indexed keywords

ANTIGEN; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; HEXAVALENT VACCINE; INFLUENZA VACCINE; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ARTICLE; CONTROLLED STUDY; DIPHTHERIA; DROWSINESS; DRUG CONJUGATION; DRUG ERUPTION; DRUG RESPONSE; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; EDEMA; ERYTHEMA; FEVER; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFLUENZA; INJECTION; INJECTION SITE; IRRITABILITY; MAJOR CLINICAL STUDY; PAIN; PERTUSSIS; PHARYNGITIS; POLIOMYELITIS; PRIORITY JOURNAL; PROTECTION; RASH; SIDE EFFECT; TETANUS; URTICARIA; VACCINATION;

DIPHTHERIA; DIPHTHERIA TOXOID; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS VACCINES; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; INFANT; MALE; PERTUSSIS VACCINE; POLIOMYELITIS; POLIOVIRUS VACCINE, INACTIVATED; POLYSACCHARIDES, BACTERIAL; TETANUS; TETANUS TOXOID; VACCINATION; VACCINES, COMBINED; WHOOPING COUGH;

EID: 2442548676     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.11.044     Document Type: Article

References (34)

1. Combination vaccines for childhood immunization. MMWR Recomm Rep 1999;48(RR-5):1-14.
2. Atkinson W.L., Pickering L.K., Schwartz B., Weniger B.G., Iskander J.K., Watson J.C. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR CDC Surveill. Summ. 51(RR-2):2002;1-35
3. Decker M.D., Edwards K.M., Steinhoff M.C., Rennels M.B., Pichichero M.E., Englund J.A., et al. Comparison of 13 acellular pertussis vaccines: adverse reactions. Pediatrics. 96(3 Pt 2):1995;557-566
4. Edwards K.M., Decker M.D. Combination vaccines: hopes and challenges. Pediatr. Infect. Dis. J. 13(5):1994;345-347
5. Lopez A.L., Blumberg D.A. An overview of the status of acellular pertussis vaccines in practice. Drugs. 54(2):1997;189-196
6. Certification of poliomyelitis eradication - European Region, June 2002. MMWR Morb Mortal Wkly Rep 2002;51(26):572-4.
7. Progress towards the global eradication of poliomyelitis, 2001. Wkly Epidemiol Rec 2002;77(13):98-107.
8. Global Programme for Vaccines and Immunization (GPV). The WHO position paper on Haemophilus influenzae type b conjugate vaccines. Wkly Epidemiol Rec 1998;73(10):64-8.
9. Van Damme P. Hepatitis B: vaccination programmes in Europe - an update. Vaccine. 19(17-19):2001;2375-2379
10. Helwig H., Mertsola J., Harvey D., Nicolopoulos D., Schaack J.C., Sedlak W. Childhood immunisation in the European Union. Confederation of European Specialists in Paediatrics (CESP). Eur. J. Pediatr. 157(8):1998;676-680
11. Hargreaves R.M., Slack M.P., Howard A.J., Anderson E., Ramsay M.E. Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme. Br. Med. J. 312(7024):1996;160-161
12. Andre F.E. Development and clinical application of new polyvalent combined paediatric vaccines. Vaccine. 17(13-14):1999;1620-1627
13. Capiau C., Poolman J., Hoet B., Bogaerts H., Andre F. Development and clinical testing of multivalent vaccines based on a diphtheria-tetanus-acellular pertussis vaccine: difficulties encountered and lessons learned. Vaccine. 21:2003;2273-2287
14. Pines E., Barrand M., Fabre P., Salomon H., Blondeau C., Wood S.C., et al. New acellular pertussis-containing paediatric combined vaccines. Vaccine. 17(13-14):1999;1650-1656
15. Braun M.M., Terracciano G., Salive M.E., Blumberg D.A., Vermeer-de Bondt P.E., Heijbel H., et al. Report of a US public health service workshop on hypotonic-hyporesponsive episode (HHE) after pertussis immunization. Pediatrics. 102(5):1998;E52
16. DuVernoy T.S., Braun M.M. Hypotonic-hyporesponsive episodes reported to the Vaccine Adverse Event Reporting System (VAERS), 1996-1998. Pediatrics. 106(4):2000;E52
17. Dagan R., Igbaria K., Piglansky L., Melamed R., Willems P., Grossi A., et al. Safety and immunogenicity of a combined pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b-etanus conjugate vaccine in infants, compared with a whole cell pertussis pentavalent vaccine. Pediatr. Infect. Dis. J. 16(12):1997;1113-1121
18. Chen C.C., Chang M.H., Lee H.C., Twu S.J., Safary A. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in healthy adolescents on two-dose schedule. Acta Paediatr. Taiwan. 40(3):1999;157-160
19. Gylca R., Gylca V., Benes O., Melnic A., Chicu V., Weisbecker C., et al. A new DTPa-HBV-IPV vaccine co-administered with Hib, compared to a commercially available DTPw-IPV/Hib vaccine co-administered with HBV, given at 6, 10 and 14 weeks following HBV at birth. Vaccine. 19(7-8):2000;825-833
20. Van Savage J., Decker M.D., Edwards K.M., Sell S.H., Karzon D.T. Natural history of pertussis antibody in the infant and effect on vaccine response. J. Infect. Dis. 161(3):1990;487-492
21. International conference on harmonization (ICH): note for guidance on statistical principals of clinical trial (E9). CPMP/ICH/363/96, adopted March 1998.
22. Schmitt H.J., Schuind A., Knuf M., Beutel K., Schulte-Wissermann H., Gahr M., et al. Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22, 505 infants. J. Pediatr. 129(5):1996;695-701
23. Schmitt H.J., Knuf M., Ortiz E., Sanger R., Uwamwezi M.C., Kaufhold A. Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections. J. Pediatr. 137(3):2000;304-312
24. Liese J.G., Stojanov S., Berut F., Minini P., Harzer E., Jow S., et al. Large scale safety study of a liquid hexavalent vaccine (D-T-acP-IPV-PRP∼T- HBs) administered at 2, 4, 6 and 12-14 months of age. Vaccine. 20:2002;448-454
25. Zepp F., Schuind A., Meyer C., Sänger R., Kaufhold A., Willems P. Safety and reactogenicity of a novel DTPa-HBV-IPV combined vaccine given along with commercial Hib vaccines in comparison with separate concomitant administration of DTPa, Hib, and OPV vaccines in infants. Pediatrics. 109:2002;1-8
26. Yeh S.H., Ward J.I., Partridge S., Marcy S.M., Lee H., Jing J., et al. Safety and immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B and polio combination vaccine in infants. Pediatr. Infect. Dis. 20:2001;973-980
27. Eskola J., Ward J., Dagan R., Goldblatt D., Zepp F., Siegrist C.A. Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis. Lancet. 354(9195):1999;2063-2068
28. Vidor E., Hoffenbach A., Fletcher M.A. Haemophilus influenzae type b vaccine: reconstitution of lyophilised PRP-T vaccine with a pertussis-containing paediatric combination vaccine, or a change in the primary series immunisation schedule, may modify the serum anti-PRP antibody responses. Curr. Med. Res. Opin. 17(3):2001;197-209
29. Poolman J., Kaufhold A., De Grave D., Goldblatt D. Clinical relevance of lower Hib response in DTPa-based combination vaccines. Vaccine. 19(17-19):2001;2280-2285
30. Dagan R., Amir J., Ashkenazi S., Hardt K., Faufhold A. Early responses to nonconjugated polyribosylribitol phosphate challenge as evidence of immune memory after combined diphtheria-tetanus-pertussis-polio-Haemophilus influenzae type b primary vaccination. Pediatr. Infect. Dis. 20:2001;587-592
31. Zepp F., Schmitt H.J., Kaufhold A., Schuind A., Knuf M., Habermehl P., et al. Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine. Eur. J. Pediatr. 156(1):1997;18-24
32. Schmitt H.J., von Kries R., Hassenpflug B., Hermann M., Siedler A., Niessing W., et al. Haemophilus influenzae type b disease: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (inactivated poliovirus)/H. influenzae type b combination vaccines. Pediatr. Infect. Dis. J. 20(8):2001;767-774
33. Kalies H, Meyer N, Siedler A, Schmitt HJ, von Kries R. Effectiveness of DTPa/Hib and DTPa-IPV/Hib combination vaccines in Germany: four year follow-up. Abstract, ESPID, 2003.
34. Avdicová M., Prikazský V., Hudecková H., Schuerman L., Willems P. Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV/Hib vaccine compared to separate concomitant injections of DTPa-IPV/Hib and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule. Eur. J. Pediatr. 161:2002;581-587